Avalon Pharma (Middle East Pharmaceutical)

Historical price data

Avalon Pharma is a publicly traded Saudi pharmaceutical company with a mission to enhance healthcare accessibility through the development and manufacturing of quality medicines. Its strategy is deeply aligned with Saudi Arabia's Vision 2030, focusing on import substitution and building domestic pharmaceutical sovereignty. The company has established itself as a significant manufacturer with WHO-GMP compliant facilities and a growing portfolio. Its achievements include a strong market position on the Tadawul and a strategic role in the national healthcare ecosystem.

Advanced pharmaceutical manufacturing and formulation development platform compliant with WHO-GMP and SFDA standards, focusing on generic drug development, innovative delivery systems, and scalable production.

Competes as a 'local champion' against multinational importers and other domestic Saudi manufacturers. Primary advantage is strategic alignment with national policy, while competition is based on product portfolio, quality, and cost in a branded generics market.